Study of Combination Therapy of Gliclazide MR and Basal Insulin Versus Insulin Monotherapy to Treat Type 2 Diabetes
Clinical trial NCT00736515 · COMPLETED
Trial details
- NCT number
- NCT00736515
- Sponsor
- Servier (Tianjin) Pharmaceutical Co. LTD.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2011-08-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.